COMMUNIQUÉS West-GlobeNewswire

MPX Announces Upgrade to OTCQX Best Market
10/10/2018
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today announced that its common shares were approved for trading in the United States on the [...]
Emerald Health Therapeutics’ Subsidiary Northern Vine Receives International Government Approvals and Completes Import and Export of Cannabis Oils for Research & Development
10/10/2018
Northern Vine receives approval from Health Canada to export to USA and import isolated CBD from the Netherlands, Colombia and China, with corresponding national permits First known export of legal cannabis products [...]
Publishing of Orion Corporation's Interim Report for January-September 2018 on 24 October 2018
10/10/2018
ORION CORPORATION PRESS RELEASE 10 OCTOBER 2018 at 13.00 EEST Publishing of Orion Corporation's Interim Report for January-September 2018 on 24 October 2018 Orion will publish its Interim Report for January-September [...]
Tyme’s SM-88 to be included in Pancreatic Cancer Action Network’s (PanCAN’s) Novel “Precision Promise(SM)” Adaptive Phase II/III Pancreatic Cancer Trial Platform
10/10/2018
Innovative trial design intended to accelerate development of pancreatic cancer therapies Potential pivotal pathway for SM-88 monotherapy in the second-line pancreatic cancer setting Also planning to test SM-88 in [...]
BeiGene Announces National Reimbursement Inclusion of VIDAZA® (Azacitidine for Injection) by the State Medical Insurance Administration in China
10/10/2018
BEIJING, China and CAMBRIDGE, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
INSYS Therapeutics Names New General Counsel
10/10/2018
PHOENIX, Oct. 10, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the [...]
Wright Medical Group N.V. Completes Acquisition of Cartiva, Inc.
10/10/2018
AMSTERDAM, The Netherlands, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced it has completed its acquisition of Cartiva, Inc. (Cartiva), an orthopaedic medical device company [...]
First Endoscopic Minimally Invasive Spinal Procedure at Reston Hospital Center is Performed by Surgeons at Virginia Spine Institute
10/10/2018
Dr. Colin Haines, assisted by Dr. Christopher Good, reshapes the future of spine care by performing the first endoscopic minimally invasive spinal procedure at Reston Hospital Center. RESTON, Va., Oct. 10, 2018 (GLOBE [...]
Virbac : Declaration of the number of shares and voting rights as of September 2018, 30.
10/10/2018
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote au 30 Septembre 2018
10/10/2018
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
PCI Biotech: Capital increase registered and listing of new shares
10/10/2018
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]
RAMSAY GENERALE DE SANTE : OPA CAPIO
10/10/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRICA. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCES [...]
RAMSAY GENERALE DE SANTE : OPA CAPIO
10/10/2018
COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]
Rule 2.9 Announcement
10/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 10 October 2018 [...]
Breadth of data at ECTRIMS underpins Novartis' relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden
10/10/2018
33 abstracts from the leading MS portfolio include data for Gilenya® (fingolimod), and investigational drugs siponimod (BAF312) and ofatumumab (OMB157) New research will be presented on neurofilaments, a biomarker for [...]
GenesisCare and Telix Enter into Strategic Collaboration Agreement to Accelerate Patient Access to New Treatments
10/10/2018
MELBOURNE, Australia and SYDNEY, Australia, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
09/10/2018
RADNOR, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study
09/10/2018
Data published in the American Journal of Hematology show more than twice as many patients taking crizanlizumab did not experience a disease-related pain crisis (also called vaso-occlusive crisis, or VOC) vs placebo [...]
Acura Pharmaceuticals, Inc. Restructures Debt Obligations
09/10/2018
PALATINE, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) , a specialty pharmaceutical company focused on innovating abuse deterrent drugs , today announced that on October 5, 2018 we [...]

Pages